COCHW vs CTAS · rev $241.0K vs P/E 51, rev $11.26B
Envoy Medical Inc. (COCHW) versus Cintas Corporation (CTAS) — a side-by-side from cached financials, not a winner call.
Envoy Medical Inc. (COCHW) common stock listed on US.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Latest reported COCHW revenue for 2025-12-31 was $241.0K. Net income was -$23.8M. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. COCHW currently screens at market cap $0.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
COCHW currently screens at market cap $0. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Not investment advice. Open the COCHW and CTAS stock pages for the full models.
Not investment advice.